Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer

Journal of Clinical Oncology

Volumn 22, Issue 18, 2004, Pages 3685-3693

  Hébert Croteau, Nicole ^a   Brisson, Jacques ^b   Latreille, Jean ^b   Rivard, Michèle ^b   Abdelaziz, Nadia ^b   Martin, Ginette ^b  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONSENSUS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADULT; AGED; BREAST TUMOR; CONSENSUS DEVELOPMENT; MIDDLE AGED; PROGNOSIS; SURVIVAL;

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CONSENSUS DEVELOPMENT CONFERENCES; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; MIDDLE AGED; PRACTICE GUIDELINES; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 4644265882     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.07.018     Document Type: Article

References (39)

1. Smith TJ, Hillner BE: Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol 19:2886-2897, 2001
2. Woolf SH: Practice guidelines: A new reality in medicine - Impact on patient care. Arch Intern Med 153:2646-2655, 1993
3. Johnson TP, Ford L, Warnecke RB, et al: Effect of a National Cancer Institute clinical alert on breast cancer practice patterns. J Clin Oncol 12:1783-1788, 1994
4. Olivotto IA, Coldman AJ, Hislop TG, et al: Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol 15:216-222, 1997
5. Guadagnoli E, Shapiro CL, Weeks JC, et al: The quality of care for treatment of early stage breast carcinoma. Cancer 83:302-309, 1998
6. Lazovich DA, Solomon CC, Thomas DB, et al: Breast conservation therapy in the United States following the 1990 National Institutes of Health consensus development conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86:628-637, 1999
7. Hébert-Croteau N, Brisson J, Latreille J, et al: Time trends in systemic adjuvant treatment for node-negative breast cancer. J Clin Oncol 17:1458-1464, 1999
8. Malin JL, Schuster MA, Kahn KA, et al: Quality of breast cancer care: What do we know? J Clin Oncol 20:4381-4393, 2002
9. Lash TL, Silliman RA, Guadagnoli E, et al: The effect of less than definitive care on breast carcinoma recurrence and mortality. Cancer 89: 1739-1747, 2000
10. Grimshaw JM, Russell IT: Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluation. Lancet 342:1317-1322, 1993
11. Worrall G, Chaulk P, Freake D: The effects of clinical practice guidelines on patient outcomes in primary care: A systematic review. CMAJ 156:1705-1712, 1997
12. Hébert-Croteau N, Brisson J, Latreille J, et al: Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85:1104-1113, 1999
13. Hébert-Croteau N, Brisson J, Latreille J, et al: Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. CMAJ 161:951-955, 1999
14. Brisson J, Major D, Pelletier É: Evaluation de l'exhaustivité du Fichier des tumeurs du Québec. Institut national de santé publique du Québec, Québec, Canada Février 2003, p 33
15. Beaupré M: Rapport annuel des nouveaux cas de cancer déclarés au fichier des tumeurs du Québec: Année 1991. Ministère de la Santé et des Services sociaux. Gouvernement du Québec, Québec, Canada 1994
16. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic co-morbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
17. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619, 1992
18. American Joint Committee on Cancer: Breast, in Manual for Staging of Cancer (ed 4). Philadelphia, PA, J B Lippincott, 1992, pp 145-150
19. Click JH, Gelber RD, Goldhirsch A, et al: Meeting highlights: Adjuvant therapy for primary breast cancer. J Natl Cancer Inst 84:1479-1485, 1992
20. Gelman R, Gelber R, Henderson IC, et al: Improved methodology for analyzing local and distant recurrence. J Clin Oncol 8:548-555, 1990
21. Goldhirsch A, Click JH, Gelber RD, et al: Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90:1601-1608, 1998
22. Pearson ML, Ganz PA, McGuigan K, et al: The case identification challenge in measuring quality of cancer care. J Clin Oncol 20:4353-4360, 2002
23. Veronesi U, Marubini E, Del Vecchio M, et al: Local recurrences and distant metastases after conservative breast cancer treatment: Partly independent events. J Natl Cancer Inst 87:19-27, 1995
24. Demicheli R, Abbattista A, Miceli R. et al: Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy. Breast Cancer Res Treat 41:177-185, 1996
25. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomized trials. Lancet 351: 1451-1467, 1998
26. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomized trials. Lancet 352:930-942, 1998
27. Goldhirsch A, Click JH, Gelber RD, et al: Meeting highlights: International consensus panel on the treatment of primary breast cancer - Seventh international conference on adjuvant therapy of primary breast cancer. J Clin Oncol 19:3817-3827, 2001
28. Mirza AN, Mirza NQ, Vlastos G, et al: Prognostic factors in node-negative breast cancer: A review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 235:10-26, 2002
29. Van de Vijver MJ, He YD, Van't Veer LJ, et al: A gene-expression signature as predictor of survival in breast cancer. N Engl J Med 347: 1999-2009, 2002
30. Kallioniemi A: Molecular signatures of breast cancer: Predicting the future. N Engl J Med 347:2067-2068, 2002
31. Woolf SH: Practices guidelines, a new reality in medicine: Methods of developing guidelines. Arch Intern Med 152:946-952, 1992
32. Davis AD, Vaisey AT: Translating guidelines into practice: A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 157:408-415, 1997
33. Davidson NE: Breast cancer consensus meetings: Vive la différence? J Clin Oncol 20: 1719-1720, 2002
34. The National Institutes of Health Consensus Development Conference: Adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 30:1-152, 2001
35. Greenfield S, Blanco DM, Elashoff RM, et al: Patterns of care related to age of breast cancer patients. JAMA 257:2766-2770, 1987
36. Ballard-Barbash R, Potosky AL, Harlan LC, et al: Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88:716-726, 1996
37. Degner LF, Kristjanson LJ, Bowman D, et al: Information needs and decisional preferences in women with breast cancer. JAMA 277:1485-1491, 1997
38. Newcomb PA, Carbone PP: Cancer treatment and age: Patient perspectives. J Natl Cancer Inst 85:1580-1584, 1993
39. Ravdin PM, Siminoff IA, Harvey JA: Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 16:515-521, 1998